跳至主要内容
临床试验/NCT06493838
NCT06493838尚未招募4 期

Clinical Efficacy of Prophylactic Intravenous Neostigmine and Atropine in Preventing Post-Dural Puncture Headache Among Parturient Undergoing Spinal Anesthesia for Cesarean Section: A Double-blind Randomized Placebo-controlled Trial

Minia University0 个研究点目标入组 180 人开始时间: 2024年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
180
主要终点
Incidence of patients with post dural puncture headache

研究概览

简要总结

Post dural puncture headache is a distressing issue, many measures tried to treat symptoms but few delt with prevention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Parturient ladies
  • Age ranges from 18 to 35 years old.
  • ASA II with elective caesarean section under sub-arachnoid block

排除标准

  • Refusal to participate
  • surgical complications necessitating a blood transfusion
  • Emergency caesarean section
  • the need for endotracheal intubation or vasopressors
  • any contraindication to regional anesthesia (such as a history of persistent cephalgia, convulsions, cerebrovascular events

研究组 & 干预措施

Control group

Placebo Comparator

intravenous 50 mL of sterile saline 0.9% injection of 0.9% after umbilical cord clamping.

干预措施: intravenous 50 mL of saline injection of 0.9% after umbilical cord clamping. (Drug)

Neostgmine group

Active Comparator

Neostigmine 20μg/kg (Neostigmine Methylsulphate 0.5 mg, Amriya Pharm.Ind.) and atropine 0.01 mg/kg (diluted in 50 ml saline; 0.9% for 10 min) following umbilical cord clamping.

干预措施: Neostigmine 20μg/kg (Neostigmine Methylsulphate 0.5 mg, Amriya Pharm.Ind.) and atropine 0.01 mg/kg (diluted in 50 ml saline; 0.9% for 10 min) following umbilical cord clamping. (Drug)

结局指标

主要结局

Incidence of patients with post dural puncture headache

时间窗: first 5 days post-partum

Number of patients develop post dural puncture headache

次要结局

  • Analgesic request(24 hours after operation)
  • Analgesc requirements(2 days after operation)
  • Severity of post dural puncture headache(first 5 days post-partum)
  • frequency of analgesic doses(5 days)
  • incidence of complications related to the procedure(6 hours after procedure)
  • onset and duration of post dural puncture headache(5 days post partum)

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Maher

Ass professor anesthesia and pain

Minia University

相似试验